Tocilizumab for giant cell arteritis: what is optimal?

Mahmut Kaymakci, Kenneth J. Warrington

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)777-779
Number of pages3
JournalClinical and experimental rheumatology
Volume41
Issue number4
DOIs
StatePublished - Apr 2023

Keywords

  • giant cell arteritis
  • tocilizumab
  • vasculitis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this